L.M. Kohn & Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
L.M. Kohn & Company's PFE Position: Q3 2025 in Review
L.M. Kohn & Company reduced its Pfizer (PFE) stake by 43% in Q3 2025, selling an estimated $367K and leaving 19,342 shares worth $493K. The position accounts for 0.59% of the portfolio, ranked #49.
L.M. Kohn & Company first reported a position in PFE in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.29M in Q4 2022. 2,811 funds tracked by Wall St. Rank hold PFE as of Q3 2025.
- L.M. Kohn & Company held 19,342 shares of Pfizer worth $493K as of Q3 2025.
- L.M. Kohn & Company sold 14,874 Pfizer shares in Q3 2025, an estimated $367K.
- Pfizer made up 0.59% of L.M. Kohn & Company's portfolio in Q3 2025, its #49 holding.
- L.M. Kohn & Company first reported a position in Pfizer in Q1 2022 and has held it in 15 quarters since.
- L.M. Kohn & Company's Pfizer position peaked at $1.29M in Q4 2022.
- 2,811 funds tracked by Wall St. Rank held Pfizer as of Q3 2025.
Based on L.M. Kohn & Company's 13F filing for Q3 2025, filed 4 Nov 2025.